wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33987218-D4BA251A-2B5B-4C0E-8DA2-1F81A407FEEB
Q33987218-D4BA251A-2B5B-4C0E-8DA2-1F81A407FEEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33987218-D4BA251A-2B5B-4C0E-8DA2-1F81A407FEEB
What targeting eosinophils has taught us about their role in diseases.
P2860
Q33987218-D4BA251A-2B5B-4C0E-8DA2-1F81A407FEEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33987218-D4BA251A-2B5B-4C0E-8DA2-1F81A407FEEB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0153ddc92574e192d504d679b4bef001667edf5
P2860
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.